Back
Scout24 SE Vs. Aligos Therapeutics, Inc. Industry Stock Comparison
Buy
58
SCOTF
Scout24 SE
Last Price:
$115.36
Seasonality Move:
-3.71%
Buy
82
ALGS
Aligos Therapeutics, Inc.
Last Price:
$13.24
Seasonality Move:
-2.85%
Buy
58
Scout24 SE (SCOTF)
is a Buy
Is Scout24 SE a Buy, Sell or Hold?
-
The current Scout24 SE [SCOTF] share price is $115.36. The Score for SCOTF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
SCOTF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Aligos Therapeutics, Inc. [ALGS] share price is $13.30. The Score for ALGS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SCOTF Stock Price Chart
What is Scout24 SE's stock price today?
-
The Scout24 SE share price today is $115.36The current trend is relatively stagnant and SCOTF is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics, Inc.'s stock price today?
-
The Aligos Therapeutics, Inc. share price today is $13.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SCOTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.07 | Sell |
| Relative Strength Index (14 RSI): | 5.69 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.36 - 115.36) | Sell |
| Bollinger Bands (100): | (103.06 - 137.04) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 81.16 | Buy |
| Chaikin Money Flow: | 127954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.2 - 10.84) | Buy |
| Bollinger Bands (100): | (7.91 - 10.67) | Buy |
SCOTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.36 | Sell |
| 20-day SMA: | 115.36 | Sell |
| 50-day SMA: | 120.05 | Sell |
| 200-day SMA: | 100.02 | Buy |
| 8-day EMA: | 115.37 | Sell |
| 20-day EMA: | 115.99 | Sell |
| 50-day EMA: | 116.24 | Sell |
| 200-day EMA: | 75.14 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.99 | Buy |
| 20-day SMA: | 9.62 | Buy |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 8.45 | Buy |
| 8-day EMA: | 11.23 | Buy |
| 20-day EMA: | 10.07 | Buy |
| 50-day EMA: | 9.41 | Buy |
| 200-day EMA: | 10.52 | Buy |
Scout24 SE Earnings Growth & SCOTF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics, Inc. Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.
Scout24 SE Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||